International Health Research
Throughout Dartmouth-Hitchcock and Dartmouth College, scientists and physicians work in partnership with volunteers from the community to develop new treatments at the cutting edge of medical practice.
Section faculty conduct research in a variety of areas including tuberculosis, tuberculosis vaccines, epidemiology and treatment of HIV infection, immunology of HIV infection, herpes simplex infection, and toxic shock syndrome.
In addition, a wide repertoire of infectious disease research topics present in the course of her role as Deputy State Epidemiologist. For example, a recent statewide outbreak of N. meningitidis has prompted a CDC collaboration toward elucidation of meningitis risk factors.
- Clinical Antimicrobial Trials center on antibiotics and novel therapies for treatment of sepsis syndrome and septic shock, as well as new antibiotics for treatment of staphylococcal infections, skin and soft tissue infections, and nosocomial pneumonia.
- The DARDAR Pediatric Program is an award from the US-based Foundation for the Treatment of Children with AIDS is supporting the establishment of a model program of comprehensive and family-centered pediatric HIV care and treatment in Dar es Salaam, Tanzania.
- HIV Immunology Research focuses on Regulatory T cells in HIV Infection and HIV in the reproductive tract.
- The New England Study of Environment and Health is a population-based care control study designed to examine environmental, and other factors, that may affect the development of urinary bladder cancer in men and women between the ages of 30 and 79 in New England.
- Toxic Shock Syndrome Research centers on laboratory and clinical studies of toxic shock syndrome, including pathogenesis, epidemiology, and treatment, under the direction of Dr. Jeffrey Parsonnet, Associate Professor of Medicine and Microbiology.
- Tuberculosis research at D-H centers around control of tuberculosis driven by HIV. Elizabeth Talbot's research interests have included improved methods for TB detection in settings with epidemic HIV, such as by use of specialized mycobacterial blood cultures and sputum processing techniques. She also has interest in methods for prevention of the activation of latent M. tuberculosis infection, such as appropriate use of prophylaxis and vaccination.